Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

TPEX/7776 stock hub

TPEX/7776 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/7776is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/7776

In the news

Latest news · TPEX/7776

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-14.7

P25 n/aP50 n/aP75 n/a

ROIC-8.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/7776 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

TWD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 987.9M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	TWD 1.4B
Price	TWD 27.6
Price currency	TWD
Sic	2834
Symbol	tpex/7776
Website	https://anyabiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.72%
EV Earnings	-15.43x
EV/FCF	-13.95x
EV/Sales	60.72x
FCF yield	-5.22%
P/B ratio	3.36x
P/S ratio	83.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	99.14%
Gross Profit	TWD 16.1M
Gross Profit Growth	-34.67%
Gross Profit Growth Q	-41.11%
Gross Profit Growth3 Y	116.85%
Net Income	TWD -64M
Pretax Margin	-389.18%
ROA	-8.15
ROCE	-14.38
ROE	-14.72
ROIC	-8.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.43%
Revenue Growth	-24.66x
Revenue Growth Q	-40.98x
Revenue Growth3 Y	112.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.04
Assets	TWD 413.9M
Cash	TWD 370.2M
Current Assets	TWD 392.7M
Current Liabilities	TWD 8.2M
Debt	TWD 3M
Debt Equity	TWD 0.01
Debt FCF	TWD -0.04
Equity	TWD 402.8M
Interest Coverage	-112.8
Liabilities	TWD 11M
Long Term Assets	TWD 21.2M
Long Term Liabilities	TWD 2.8M
Net Cash	TWD 367.3M
Net Cash By Market Cap	TWD 27.1
Net Cash Growth	-18.52%
Net Debt Equity	TWD -0.91
Tangible Book Value	TWD 396.8M
Tangible Book Value Per Share	TWD 8.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	47.95
Net Working Capital	TWD 14.4M
Quick ratio	47.27
Working Capital	TWD 384.5M
Working Capital Turnover	TWD 0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-48.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.43%
200-day SMA	42.1
50-day SMA	31.22
50-day SMA vs 200-day SMA	50under200
All Time High	82.3
All Time High Change	-66.46%
All Time High Date	2024-10-25
All Time Low	19.05
All Time Low Change	44.88%
All Time Low Date	2025-04-09
ATR	1.95
Beta1y	-0.45
Beta2y	0.28
Ch YTD	-42.26
High	28.1
High52	70.6
High52 Date	2025-09-01
High52ch	-60.91%
Low	26.9
Low52	25.2
Low52 Date	2026-05-05
Low52ch	9.52%
Ma50ch	-11.58%
Price vs 200-day SMA	-34.44%
RSI	42.38
RSI Monthly	39.68
RSI Weekly	35.7
Sharpe ratio	0.09x
Sortino ratio	0.28
Total Return	-48.38%
Tr YTD	-42.26
Tr1m	-8.31%
Tr1w	0.55%
Tr3m	-26.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -58.3M
Operating margin	-358.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,299,179%
Net Borrowing	-160,000
Shares Insiders	21.45%
Shares Institutions	2.96%
Shares Out	49,101,000
Shares Qo Q	0%
Shares Yo Y	48.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -70.8M
Average Volume	89,082.85x
Bv Per Share	8.2
CAPEX	TWD -872,000
Ch1m	-8.31
Ch1w	0.55
Ch1y	-1.43
Ch3m	-26.4
Ch6m	-45.02
Change	-0.9%
Change From Open	-1.78
Close	27.85
Days Gap	0.9
Depreciation Amortization	1,507,000
Dollar Volume	1,000,941.6
Earnings Date	2026-05-11
EBIT	TWD -58.3M
EBITDA	TWD -56.8M
EPS	TWD -1.3
F Score	1
FCF	TWD -70.8M
FCF EV Yield	-7.17x
FCF Per Share	TWD -1.44
Financing CF	-160,000
Fiscal Year End	December
Founded	2,016
Income Tax	TWD 685,000
Investing CF	-69,686,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Ma150	40.63
Ma150ch	-32.07%
Ma20	28.44
Ma20ch	-2.94%
Net CF	-139,474,000
Next Earnings Date	2026-05-11
Open	28.1
Position In Range	58.33
Ppne	8,735,000
Price Date	2026-05-08
Ptbv Ratio	3.41
Relative Volume	0.41x
Revenue	16,271,000x
Tax By Revenue	4.21x
Tr6m	-45.02%
Volume	36,266
Z Score	108.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/7776 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/7776 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/7776?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.0%

Share of float held by funds and institutions

Insider ownership

+21.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+48.4%

Negative means the company is buying back shares.

Technical

TPEX/7776 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.4

Neutral momentum band

Price vs 200-day MA

-34.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/7776

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7776 stock rating?

tpex/7776 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7776 analysis?

The full report lives at /stocks/tpex/7776/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7776?

The latest report frames tpex/7776 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7776 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.